Figure 4

Effectiveness of the model in different T stages and different molecular types of breast cancer. (A, B) Female patients with early (T1 or T2) breast cancer; (C) different breast cancer molecular subtypes in the total set.

Effectiveness of the model in different T stages and different molecular types of breast cancer. (A, B) Female patients with early (T1 or T2) breast cancer; (C) different breast cancer molecular subtypes in the total set.